— Know what they know.
Not Investment Advice
Also trades as: 300347.SZ (SHZ) · $vol 183M · 3347.HK (HKSE) · $vol 11M

HNGZY Earnings

Hangzhou Tigermed Consulting Co., Ltd
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +11.2% 1Y: +11.2% 3Y: -59.8%
$4.45
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 50 · $6.9B mcap · 626M float · 0.0000% daily turnover
Last Earnings 2026-04-28
EPS
¥0.01 (US$0.00)
▲ Beat +0.0%
Revenue
¥262M ($39M)
▼ Miss -0.1%
Next Earnings Qtr ending 2026-12-30 · date TBD
Revenue Estimate
¥2.1B ($318M)
2 analysts
1 USD = 6.70 CNY

Estimate vs Actual

Earnings Surprise History

0/20
EPS Beats
0/20
Revenue Beats
0%
EPS Beat Rate
0%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-09-21 annual 2027-12-31 ¥— ¥— — ¥8,899,244,220 ¥8,903,587,100
2026-09-21 annual 2026-12-31 ¥— ¥— — ¥7,779,529,110 ¥7,783,711,540
2026-09-10 annual 2027-12-31 ¥— ¥— — ¥8,839,672,890 ¥8,899,244,220
2026-09-10 annual 2026-12-31 ¥— ¥— — ¥7,814,351,020 ¥7,779,529,110
2026-09-03 annual 2027-12-31 ¥— ¥— — ¥8,826,041,800 ¥8,839,672,890
2026-09-03 annual 2026-12-31 ¥— ¥— — ¥7,816,178,940 ¥7,814,351,020
2026-09-03 quarter 2026-12-30 ¥— ¥— — ¥2,215,667,000 ¥2,133,538,480
2026-09-03 quarter 2026-09-30 ¥— ¥— — ¥2,043,659,000 ¥2,007,310,760
2026-09-02 annual 2026-12-31 ¥— ¥— — ¥7,670,503,170 ¥7,816,178,940
2026-09-02 annual 2027-12-31 ¥— ¥— — ¥8,708,268,120 ¥8,826,041,800
2026-09-02 quarter 2026-09-30 ¥— ¥— — ¥1,969,062,360 ¥2,043,659,000
2026-09-02 quarter 2026-12-30 ¥— ¥— — ¥2,091,962,350 ¥2,215,667,000
2026-09-01 annual 2026-12-31 ¥— ¥— — ¥7,676,005,750 ¥7,670,503,170
2026-09-01 annual 2027-12-31 ¥— ¥— — ¥8,711,524,410 ¥8,708,268,120
2026-09-01 quarter 2026-12-30 ¥— ¥— — ¥— ¥2,091,962,350
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms